Go to London Stock Exchange Group Website

GSK  GLAXOSMITHKLINE PLC  ORD 25P

GLAXOSMITHKLINE  Currency GBX  Primary Listed Share

Company

Price +/- % +/- Bid Offer Volume High Low Last close
1,254.00 Up+13.50 +1.09% 1,253.50 1,254.00 12,197,232 1,250.40 1,235.90 1,253.50 on 20-Nov-2009
As at 21-Nov-2009 09:04:53 - All data delayed by at least 15 minutes.
This company is quoted on  Market

Share price performance

Last 5 trades
Time/Date Price Volume Trade value Type
17:05:37  20-Nov-09 1,253.50 149 1,867.72 NT
16:38:43  20-Nov-09 1,249.66 100,000 1,249,660.00 NT
16:38:48  20-Nov-09 1,249.66 100,000 1,249,664.40 C
16:43:43  20-Nov-09 1,248.00 389,027 4,855,056.96 NT
16:36:12  20-Nov-09 1,252.87 9,200 115,264.04 O

Trading Information
21-Nov-2009
FTSE index FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SET0
MiFID Status Regulated Market
Exchange market size 4,000
SEDOL 0925288
ISIN number GB0009252882


Company Fundamentals
More
Interim (£m) 2008 (£m) 2007 (£m) 2006 (£m) 2005 (£m)
Currency GBP GBP GBP GBP GBP
Total op. expenses -10,068.00 -17,752.00 -15,598.00 -15,724.00 -15,150.00
P/L for the financial year 2,566.00 4,602.00 5,214.00 5,389.00 4,689.00
Retained profit/loss 980.00 1,673.00 2,421.00 2,791.00 2,299.00
Total assets 35,961.00 39,393.00 31,003.00 25,553.00 27,198.00
Total liabilities -35,961.00 -39,393.00 -31,003.00 -25,553.00 -27,198.00

Latest news stories
More
Time/Date Headline
17:14 18-Nov-09    Blocklisting Interim Review
17:49 11-Nov-09    Director/PDMR Shareholding
17:01 11-Nov-09    Director/PDMR Shareholding
15:13 09-Nov-09    Director/PDMR Shareholding
17:00 05-Nov-09    Director/PDMR Shareholding

Company Information
Updated Monthly
Company address C8 Gsk House, 980 Great West Road, Brentford, TW8 9GS, United Kingdom
Company website http://www.gsk.com
Market cap(in millions)* £ 65,045.19
Listing/Admission to trading 22 May 1972
Trading system SETS
Market MAINMARKET
Activities A group engaged in the creation; discovery; development; manufacture and marketing of pharmaceutical and consumer health-related products
Auditor PricewaterhouseCoopers LLP
Financial Advisor Goldman Sachs International, Morgan Stanley
Broker RBS Hoare Govett Ltd, UBS
Solicitor Slaughter and May
Registrar Equiniti Ltd

*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are subject to change. Last updated: 20-Nov-2009



GLAXOSMITHKLINE price